You may see claims that berberine boosts GLP-1. Some preclinical work suggests gut-hormone changes may happen, but even if that is true, it is not the same magnitude or reliability as a prescription GLP-1 agonist
If you are currently on semaglutide or compounded tirzepatide , switching to retatrutide means moving to a research-stage compound with less long-term safety data
[1] [2] Symptoms that have been described include: Injection site reactions : redness, swelling, itching, or mild bruising at the site of subcutaneous administration consistent with class effects seen with semaglutide and tirzepatide (see eMC SmPCs for Wegovy, Ozempic, and Mounjaro for comparator data) Pruritus or urticaria : patchy or widespread skin itching or redness, which may reflect a hypersensitivity response again consistent with known class effects of GLP-1-based therapies [17] Generalised skin sensitivity : heightened sensitivity to touch, temperature, or pressure beyond the injection site
How Is Retatrutide Administered
Clin Kidney J 15(8):15931600